Brief: Xeris Biopharma Announces Private Exchange Of Convertible Notes
Thu 12:05
BRIEF-Xeris Biopharma Announces Private Exchange Of Convertible Notes June 11 (Reuters) - Xeris Biopharma Holdings Inc XERS.O:
XERIS BIOPHARMA ANNOUNCES PRIVATE EXCHANGE OF CONVERTIBLE NOTES
XERIS BIOPHARMA - TO RETIRE $23 MILLION PRINCIPAL OF NOTES FOR $23 MILLION CASH AND SHARES
Source text: ID:nBw4gglnva
Further company coverage: XERS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Announces Private Exchange Of Convertible Notes
Xeris Biopharma Q1 product revenue jumps 43%, beats estimates
Brief: Xeris Biopharma Q4 Product Revenue USD 83.43 Million Versus. Ibes Estimate USD 82.3 Million
Xeris Biopharma Q4 product revenue beats analyst expectations, driven by higher patient demand
Brief: Xeris Biopharma Subsidiaries File Recorlev Patent Infringement Lawsuit